ロード中...
Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
INTRODUCTION: Disease-modifying treatments for Alzheimer's disease (AD) are likely to be offered only to patients with molecular evidence for Alzheimer pathology and expanded to patients with prodromal AD. We calculated the potential future costs of expanding the number of positron emission tom...
保存先:
| 出版年: | Alzheimers Dement (N Y) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709060/ https://ncbi.nlm.nih.gov/pubmed/31463360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.06.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|